These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16878609)

  • 1. Clinical experience with the TandemHeart percutaneous ventricular assist device.
    Kar B; Adkins LE; Civitello AB; Loyalka P; Palanichamy N; Gemmato CJ; Myers TJ; Gregoric ID; Delgado RM
    Tex Heart Inst J; 2006; 33(2):111-5. PubMed ID: 16878609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience and patient outcomes associated with the TandemHeart percutaneous transseptal assist device among a heterogeneous patient population.
    Tempelhof MW; Klein L; Cotts WG; Benzuly KH; Davidson CJ; Meyers SN; McCarthy PM; Malaisrie CS; McGee EC; Beohar N
    ASAIO J; 2011; 57(4):254-61. PubMed ID: 21546824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge).
    Gregoric ID; Jacob LP; La Francesca S; Bruckner BA; Cohn WE; Loyalka P; Kar B; Frazier OH
    Tex Heart Inst J; 2008; 35(2):125-9. PubMed ID: 18612448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with the TandemHeart percutaneous ventricular assist device as a bridge to cardiac transplantation.
    Bruckner BA; Jacob LP; Gregoric ID; Loyalka P; Kar B; Cohn WE; La Francesca S; Radovancevic B; Frazier OH
    Tex Heart Inst J; 2008; 35(4):447-50. PubMed ID: 19156239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of percutaneous left ventricular assist device as a bridge to recovery from myocarditis.
    Chandra D; Kar B; Idelchik G; Simpson L; Loyalka P; Gregoric ID; Delgado RM; Frazier OH
    Am J Cardiol; 2007 Jun; 99(12):1755-6. PubMed ID: 17560889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG.
    Vranckx P; Schultz CJ; Valgimigli M; Eindhoven JA; Kappetein AP; Regar ES; Van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):302-10. PubMed ID: 19360865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous left ventricular assist device, TandemHeart, for high-risk percutaneous coronary revascularization. A single centre experience.
    Giombolini C; Notaristefano S; Santucci S; Fortunati F; Savino K; Sindaco FD; Ragni T; Allegri M; Ambrosio G
    Acute Card Care; 2006; 8(1):35-40. PubMed ID: 16720426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful high-risk coronary angioplasty in a patient with cardiogenic shock under circulatory assist with a 16F axial flow pump.
    Ferrari M; Aboulhosn W; Figulla HR
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):557-61. PubMed ID: 16270359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TandemHeart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience.
    Vranckx P; Meliga E; De Jaegere PP; Van den Ent M; Regar ES; Serruys PW
    EuroIntervention; 2008 Nov; 4(3):331-7. PubMed ID: 19110806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous ventricular assist device placement during active cardiopulmonary resuscitation for severe refractory cardiogenic shock after acute myocardial infarction.
    Idelchik GM; Loyalka P; Kar B
    Tex Heart Inst J; 2007; 34(2):204-8. PubMed ID: 17622370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock.
    Thomas JL; Al-Ameri H; Economides C; Shareghi S; Abad DG; Mayeda G; Burstein S; Shavelle DM
    J Invasive Cardiol; 2010 Aug; 22(8):360-4. PubMed ID: 20679671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock.
    Windecker S
    Curr Opin Crit Care; 2007 Oct; 13(5):521-7. PubMed ID: 17762230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of patients with cardiogenic shock treated with TandemHeart
    Smith L; Peters A; Mazimba S; Ragosta M; Taylor AM
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1173-1181. PubMed ID: 29745477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance.
    Thiele H; Lauer B; Hambrecht R; Boudriot E; Cohen HA; Schuler G
    Circulation; 2001 Dec; 104(24):2917-22. PubMed ID: 11739306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: single-center experience.
    Rajdev S; Krishnan P; Irani A; Kim MC; Moreno PR; Sharma SK; Kini AS
    J Invasive Cardiol; 2008 Feb; 20(2):67-72. PubMed ID: 18252970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
    Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW
    Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TandemHeart insertion via a femoral arterial GORE-TEX graft conduit in a high-risk patient.
    Busch J; Torre-Amione G; Noon GP; Loebe M
    Tex Heart Inst J; 2008; 35(4):462-5. PubMed ID: 19156243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical introduction of the Tandemheart, a percutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary intervention.
    Vranckx P; Foley DP; de Feijter PJ; Vos J; Smits P; Serruys PW
    Int J Cardiovasc Intervent; 2003; 5(1):35-9. PubMed ID: 12623563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-risk PTCA assisted by the Hemopump 14F: the Geneva experience].
    Panos A; Kalangos A; Urban P
    Schweiz Med Wochenschr; 1999 Oct; 129(42):1529-34. PubMed ID: 10568235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.